DK1225902T3 - Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden - Google Patents

Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden

Info

Publication number
DK1225902T3
DK1225902T3 DK00969966T DK00969966T DK1225902T3 DK 1225902 T3 DK1225902 T3 DK 1225902T3 DK 00969966 T DK00969966 T DK 00969966T DK 00969966 T DK00969966 T DK 00969966T DK 1225902 T3 DK1225902 T3 DK 1225902T3
Authority
DK
Denmark
Prior art keywords
ciclesonide
mucosa
administration
pharmaceutical composition
containing pharmaceutical
Prior art date
Application number
DK00969966T
Other languages
Danish (da)
English (en)
Inventor
Atsuhiro Nagano
Yoshihisa Nishibe
Kazuya Takanashi
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1225902(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK1225902T3 publication Critical patent/DK1225902T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00969966T 1999-10-20 2000-10-20 Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden DK1225902T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29818599 1999-10-20
PCT/JP2000/007350 WO2001028562A1 (en) 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa

Publications (1)

Publication Number Publication Date
DK1225902T3 true DK1225902T3 (da) 2005-05-02

Family

ID=17856327

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00969966T DK1225902T3 (da) 1999-10-20 2000-10-20 Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden

Country Status (35)

Country Link
US (1) US6767901B1 (cs)
EP (1) EP1225902B1 (cs)
JP (1) JP4264211B2 (cs)
KR (1) KR100722209B1 (cs)
CN (2) CN101869570B (cs)
AR (1) AR026072A1 (cs)
AT (1) ATE285779T1 (cs)
AU (1) AU781895B2 (cs)
BG (1) BG65818B1 (cs)
BR (1) BRPI0014878B8 (cs)
CA (1) CA2388322C (cs)
CO (1) CO5261494A1 (cs)
CZ (1) CZ297779B6 (cs)
DE (1) DE60017175T2 (cs)
DK (1) DK1225902T3 (cs)
EA (1) EA006015B1 (cs)
ES (1) ES2234681T3 (cs)
HR (1) HRP20020346B1 (cs)
HU (1) HU228893B1 (cs)
IL (2) IL148691A0 (cs)
ME (1) ME00567A (cs)
MX (1) MXPA02003974A (cs)
MY (1) MY136987A (cs)
NO (1) NO327444B1 (cs)
NZ (1) NZ518298A (cs)
PE (1) PE20010712A1 (cs)
PL (1) PL199702B1 (cs)
PT (1) PT1225902E (cs)
RS (1) RS50310B (cs)
SI (1) SI1225902T1 (cs)
SK (1) SK286196B6 (cs)
TR (1) TR200200841T2 (cs)
TW (1) TWI225788B (cs)
WO (1) WO2001028562A1 (cs)
ZA (1) ZA200203077B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
EA009843B1 (ru) * 2002-07-02 2008-04-28 Никомед Гмбх Содержащая циклесонид стерильная водная суспензия
US7221586B2 (en) 2002-07-08 2007-05-22 Micron Technology, Inc. Memory utilizing oxide nanolaminates
AU2003261225A1 (en) * 2002-07-26 2004-02-16 Fmc Corporation Production of microcrystalline cellulose
JP4746318B2 (ja) * 2002-08-30 2011-08-10 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング シクレソニドと抗ヒスタミン剤との組合せ物を含有するアレルギー性鼻炎の治療用医薬組成物
ES2312844T3 (es) * 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
US8371292B2 (en) 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070134165A1 (en) * 2004-04-20 2007-06-14 Altana Pharma Ag Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
EP1796679A1 (en) * 2004-09-10 2007-06-20 Altana Pharma AG Ciclesonide and syk inhibitor combination and methods of use thereof
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
MX2010009961A (es) * 2008-03-14 2010-09-30 Cephalon Inc Composicion transmucosica mejorada y forma de dosificacion.
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
KR100683510B1 (ko) * 1998-01-22 2007-02-16 산텐 세이야꾸 가부시키가이샤 플루오로메톨론 현탁형 점안제
SE514128C2 (sv) 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Also Published As

Publication number Publication date
SI1225902T1 (en) 2005-06-30
BG65818B1 (bg) 2010-01-29
HK1050858A1 (zh) 2003-07-11
HUP0203339A3 (en) 2004-07-28
ME00567B (me) 2011-12-20
WO2001028562A1 (en) 2001-04-26
IL148691A (en) 2006-12-10
PL356191A1 (en) 2004-06-14
HUP0203339A2 (hu) 2003-02-28
CA2388322A1 (en) 2001-04-26
CN1379674A (zh) 2002-11-13
KR20020059627A (ko) 2002-07-13
AR026072A1 (es) 2002-12-26
KR100722209B1 (ko) 2007-05-29
ME00567A (en) 2011-12-20
BRPI0014878B8 (pt) 2021-05-25
MY136987A (en) 2008-12-31
CN1379674B (zh) 2014-10-29
MXPA02003974A (es) 2003-09-25
BR0014878A (pt) 2002-06-11
YU28002A (sh) 2004-11-25
PL199702B1 (pl) 2008-10-31
AU7953100A (en) 2001-04-30
NZ518298A (en) 2003-11-28
SK6922002A3 (en) 2002-09-10
HU228893B1 (hu) 2013-06-28
PT1225902E (pt) 2005-05-31
ATE285779T1 (de) 2005-01-15
AU781895B2 (en) 2005-06-23
CN101869570A (zh) 2010-10-27
PE20010712A1 (es) 2001-07-12
HRP20020346B1 (hr) 2011-06-30
IL148691A0 (en) 2002-09-12
SK286196B6 (sk) 2008-05-06
NO20021898L (no) 2002-04-22
CZ297779B6 (cs) 2007-03-28
ZA200203077B (en) 2003-02-26
ES2234681T3 (es) 2005-07-01
CN101869570B (zh) 2012-10-10
EA200200375A1 (ru) 2002-10-31
BRPI0014878B1 (pt) 2015-08-11
EP1225902A1 (en) 2002-07-31
US6767901B1 (en) 2004-07-27
JP4264211B2 (ja) 2009-05-13
HK1149719A1 (en) 2011-10-14
CA2388322C (en) 2007-09-18
RS50310B (sr) 2009-09-08
EA006015B1 (ru) 2005-08-25
EP1225902B1 (en) 2004-12-29
TR200200841T2 (tr) 2002-07-22
TWI225788B (en) 2005-01-01
CZ20021238A3 (cs) 2002-07-17
HRP20020346A2 (en) 2004-02-29
NO20021898D0 (no) 2002-04-22
DE60017175D1 (de) 2005-02-03
BG106512A (bg) 2002-12-29
DE60017175T2 (de) 2005-12-29
NO327444B1 (no) 2009-06-29
JP2003512329A (ja) 2003-04-02
CO5261494A1 (es) 2003-03-31

Similar Documents

Publication Publication Date Title
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
NO20015175L (no) Farmasöytisk sammensetning
FI991485L (fi) Uusi farmaseuttinen koostumus
DK1208864T4 (da) Forbedringer til lægemiddelafgivelsesindretninger
PT1242087E (pt) Composicoes farmaceuticas
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
NO20020086D0 (no) Smaksmaskerte farmasöytiske flytende formuleringer
EE05020B1 (et) Glburiidi ravimkoostis
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
DK1334717T3 (da) Farmaceutiske sammensætninger til oral og topisk administrering
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
PT1239832E (pt) Composicoes farmaceuticas
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus
EE200100281A (et) Analgeetiline ravimkoostis
AR025867A1 (es) Formulacion portasdora farmaceutica
EA200201062A1 (ru) Фармацевтическая композиция на основе нестероидного противовоспалительного средства
ID30249A (id) Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah
ITTO20020672A0 (it) Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
GB9902227D0 (en) Pharmaceutical composition for topical administration
ITMI992202A0 (it) Composizioni farmaceutiche contenenti farmaci antiinfiammatori
AR018092A1 (es) Composicion farmaceutica liquida para administracion oral
DK1165081T3 (da) Fremgangsmåde til fremstilling af tolperisonholdige farmaceutiske præparater til oral indgivelse